Antitumour and antioxidant activity of Scutia myrtina against Ehrlich ascites carcinoma in Swiss albino mice. 2012

Ramanathan Sambath Kumar, and Kupusamy Asok Kumar, and Nallasamy Venkateswara Murthy
Department of Pharmaceutics and Pharmacology, Faculty of Pharmacy, 7th of April University, Al-Zawia, Libya. sambathju2002@yahoo.co.in

The aim of this study is to investigate the antitumour and antioxidant activities of the ethanol extract of Scutia myrtina (EESM) against Ehrlich's ascites carcinoma (EAC) in mice. Twenty-four hours after tumour inoculation, EESM was administered at doses 100, 200 and 300 mg kg⁻¹ bodyweight/mice/day for 21 days. EESM caused a significant (p < 0.01) decrease in ascites volume, packed cell volume and viable cell count, and also prolonged the life span of EAC tumour-bearing mice. Haematological profiles reverted to near-normal levels in extract-treated mice (p < 0.01). EESM also produced protective effects by significantly decreasing the activity of serum enzymes and bilirubin and increasing the protein and uric acid levels (p < 0.05). EESM significantly (p < 0.05) decreased the levels of lipid peroxidation, while it significantly (p < 0.05) increased the levels of enzymatic and non-enzymatic antioxidants. The results indicate that EESM exhibited significant antitumour and antioxidant activities in EAC-bearing mice.

UI MeSH Term Description Entries
D008297 Male Males
D002286 Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. Ehrlich Ascites Tumor,Ascites Tumor, Ehrlich,Ehrlich Tumor Carcinoma,Tumor, Ehrlich Ascites
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D023041 Xenograft Model Antitumor Assays In vivo methods of screening investigative anticancer drugs, biologic response modifiers or radiotherapies. Human tumor tissue or cells are transplanted into mice or rats followed by tumor treatment regimens. A variety of outcomes are monitored to assess antitumor effectiveness. Tumor Xenograft Assay,Xenograft Antitumor Assays,Antitumor Assays, Xenograft Model,Antitumor Assay, Xenograft,Antitumor Assays, Xenograft,Assay, Tumor Xenograft,Assay, Xenograft Antitumor,Assays, Tumor Xenograft,Assays, Xenograft Antitumor,Tumor Xenograft Assays,Xenograft Antitumor Assay,Xenograft Assay, Tumor,Xenograft Assays, Tumor

Related Publications

Ramanathan Sambath Kumar, and Kupusamy Asok Kumar, and Nallasamy Venkateswara Murthy
October 2011, Asian Pacific journal of tropical medicine,
Ramanathan Sambath Kumar, and Kupusamy Asok Kumar, and Nallasamy Venkateswara Murthy
January 2021, Nutrition and cancer,
Ramanathan Sambath Kumar, and Kupusamy Asok Kumar, and Nallasamy Venkateswara Murthy
September 2017, Oncology letters,
Ramanathan Sambath Kumar, and Kupusamy Asok Kumar, and Nallasamy Venkateswara Murthy
January 2013, Indian journal of pharmacology,
Ramanathan Sambath Kumar, and Kupusamy Asok Kumar, and Nallasamy Venkateswara Murthy
January 2015, Pharmacognosy research,
Ramanathan Sambath Kumar, and Kupusamy Asok Kumar, and Nallasamy Venkateswara Murthy
January 2012, Natural product research,
Ramanathan Sambath Kumar, and Kupusamy Asok Kumar, and Nallasamy Venkateswara Murthy
December 2021, The Libyan journal of medicine,
Ramanathan Sambath Kumar, and Kupusamy Asok Kumar, and Nallasamy Venkateswara Murthy
May 2012, Asian Pacific journal of tropical biomedicine,
Ramanathan Sambath Kumar, and Kupusamy Asok Kumar, and Nallasamy Venkateswara Murthy
May 2019, Clinical and experimental pharmacology & physiology,
Ramanathan Sambath Kumar, and Kupusamy Asok Kumar, and Nallasamy Venkateswara Murthy
May 2010, Molecular and cellular biochemistry,
Copied contents to your clipboard!